Envestnet Asset Management
PCVX icon

Envestnet Asset Management’s Vaxcyte PCVX Stock Holding History

Envestnet Asset Management’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.1M Sell
70,581
-27,574
-28% -$1.5M ﹤0.01% 2609
2026
Q1 		$5.7M Buy
98,155
+47,357
+93% +$2.57M ﹤0.01% 2229
2025
Q4 		$2.34M Sell
50,798
-19,013
-27% -$850K ﹤0.01% 2712
2025
Q3 		$2.51M Sell
69,811
-4,196
-6% -$139K ﹤0.01% 2733
2025
Q2 		$2.41M Sell
74,007
-22,593
-23% -$741K ﹤0.01% 2699
2025
Q1 		$3.65M Buy
96,600
+41,517
+75% +$3.32M ﹤0.01% 2343
2024
Q4 		$4.51M Buy
55,083
+6,121
+13% +$608K ﹤0.01% 2169
2024
Q3 		$5.59M Buy
48,962
+1,001
+2% +$90.2K ﹤0.01% 2031
2024
Q2 		$3.62M Buy
47,961
+5,268
+12% +$359K ﹤0.01% 2239
2024
Q1 		$2.92M Sell
42,693
-6,169
-13% -$427K ﹤0.01% 2339
2023
Q4 		$3.07M Buy
48,862
+9,393
+24% +$488K ﹤0.01% 2205
2023
Q3 		$2.01M Buy
39,469
+17,117
+77% +$844K ﹤0.01% 2375
2023
Q2 		$1.12M Buy
22,352
+12,469
+126% +$591K ﹤0.01% 2673
2023
Q1 		$370K Buy
9,883
+2,684
+37% +$114K ﹤0.01% 3336
2022
Q4 		$345K Buy
+7,199
New +$283K ﹤0.01% 3335

Other funds holding PCVX

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Envestnet Asset Management's PCVX Position: Q2 2026 in Review

Envestnet Asset Management reduced its Vaxcyte (PCVX) stake by 28% in Q2 2026, selling an estimated $1.5M and leaving 70,581 shares worth $4.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2609.

Envestnet Asset Management first reported a position in PCVX in Q4 2022 and has held it in 15 quarters since. The position peaked at $5.7M in Q1 2026. 87 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Envestnet Asset Management held 70,581 shares of Vaxcyte worth $4.1M as of Q2 2026.
  • Envestnet Asset Management sold 27,574 Vaxcyte shares in Q2 2026, an estimated $1.5M.
  • Vaxcyte made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #2609 holding.
  • Envestnet Asset Management first reported a position in Vaxcyte in Q4 2022 and has held it in 15 quarters since.
  • Envestnet Asset Management's Vaxcyte position peaked at $5.7M in Q1 2026.
  • 87 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.